AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34807321 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention
Number of subjects: 0
Study 34807321 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief intervention
Number of subjects: 0
Study 34807321 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 0
Study 33941941 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain Rating index group (PRi group)
Number of subjects: 44
Study 33941941 — intervention group
Group type: COMPARATOR
Intervention: Systolic blood pressure group (SBP group)
Number of subjects: 44
Study 33799350 — intervention group
Group type: EXPERIMENTAL
Intervention: 9 month regimen consisting of levofloxacin, rifampicin, ethambutol, pyrazinamide, plus a second‐line injectable in the first 3 months
Number of subjects: 132
Study 32388522 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser therapy (diode laser, λ: 645 nm) administered for three consecutive days starting on day 1 (T0)
Number of subjects: 60
Study 32388522 — intervention group
Group type: COMPARATOR
Intervention: Sham therapy (placebo)
Number of subjects: 60
Study 34993836 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based high-intensity interval training (HIIT)
Number of subjects: 21
Study 34993836 — intervention group
Group type: COMPARATOR
Intervention: Home-based moderate-intensity continuous training (MICT)
Number of subjects: 21
Study 32574096 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Boxing Group (VBG)
Number of subjects: 40
Study 32574096 — intervention group
Group type: EXPERIMENTAL
Intervention: Real Boxing Group (RBG)
Number of subjects: 40
Study 32574096 — intervention group
Group type: COMPARATOR
Intervention: Control (no specific control group mentioned)
Number of subjects: 40
Study 35257166 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple nursing interventions (group training, counselling, reminder phone calls, delivery materials)
Number of subjects: 134
Study 35257166 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 134
Study 35512252 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin, 10 mg daily
Number of subjects: 2733
Study 35512252 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2733
Study 35512252 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholestanol-to-cholesterol ratio (3rd vs. 1st tertile)
Number of subjects: 2733
Study 35512252 — intervention group
Group type: EXPERIMENTAL
Intervention: Lathosterol-to-cholesterol ratio (3rd vs. 1st tertile)
Number of subjects: 2733
Study 33904823 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led, home-based heart failure self-management program (HOM-HEMP)
Number of subjects: 11
Study 35582748 — intervention group
Group type: EXPERIMENTAL
Intervention: Brivaracetam (BRV) 50-200 mg/day
Number of subjects: 738
Study 35582748 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 738
Study 33653749 — intervention group
Group type: EXPERIMENTAL
Intervention: WeChat‐VRT group
Number of subjects: 50
Study 33653749 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC) group
Number of subjects: 50
Study 32580710 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting-mimicking diet (FMD) plus usual care
Number of subjects: 100
Study 32580710 — intervention group
Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 100
Study 32580710 — intervention group
Group type: EXPERIMENTAL
Intervention: FMD plus usual care
Number of subjects: 100
Study 35012310 — intervention group
Group type: EXPERIMENTAL
Intervention: PS-GOS-enriched beverage (2 g PS/day and 4.3 g GOS/day)
Number of subjects: 0
Study 35012310 — intervention group
Group type: COMPARATOR
Intervention: PS-enriched beverage (2 g PS/day)
Number of subjects: 0
Study 35012310 — intervention group
Group type: EXPERIMENTAL
Intervention: Both beverages (PS and PS-GOS)
Number of subjects: 0
Study 33306213 — intervention group
Group type: COMPARATOR
Intervention: R-CHOP
Number of subjects: 160
Study 33306213 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive chemotherapy
Number of subjects: 160
Study 33306213 — intervention group
Group type: COMPARATOR
Intervention: CNS involvement
Number of subjects: 160
Study 33306213 — intervention group
Group type: EXPERIMENTAL
Intervention: No CNS disease
Number of subjects: 160
Study 33306213 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated IPI score and CNS disease
Number of subjects: 160
Study 33306213 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment
Number of subjects: 160
Study 32211084 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Flow Nasal Cannula (HFNC)
Number of subjects: 0
Study 32211084 — intervention group
Group type: COMPARATOR
Intervention: Conventional Oxygen Therapy (COT)
Number of subjects: 0
Study 34875850 — intervention group
Group type: EXPERIMENTAL
Intervention: Viable allogeneic disc tissue supplementation
Number of subjects: 218
Study 34875850 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 218
Study 32228635 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic sport drink (SPD)
Number of subjects: 9
Study 32228635 — intervention group
Group type: EXPERIMENTAL
Intervention: Skim milk (SM)
Number of subjects: 9
Study 36254073 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol anesthesia
Number of subjects: 36
Study 36254073 — intervention group
Group type: COMPARATOR
Intervention: Desflurane anesthesia
Number of subjects: 36
Study 34918714 — intervention group
Group type: EXPERIMENTAL
Intervention: Aloe ferox (460 mg, 2 capsules/day for 2 weeks, followed by a 2-week break, repeated 3 times)
Number of subjects: 20
Study 34918714 — intervention group
Group type: COMPARATOR
Intervention: Placebo (diet only)
Number of subjects: 20
Study 32894102 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-1-positive women, treatment-naive, tested for transmitted drug resistance mutations (TDRM)
Number of subjects: 763
Study 32894102 — intervention group
Group type: EXPERIMENTAL
Intervention: Israeli-born women
Number of subjects: 763
Study 32894102 — intervention group
Group type: COMPARATOR
Intervention: Women diagnosed between 2010-2012
Number of subjects: 763
Study 32894102 — intervention group
Group type: COMPARATOR
Intervention: Women diagnosed between 2016-2018
Number of subjects: 763
Study 32894102 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall trend
Number of subjects: 763
Study 34861767 — intervention group
Group type: EXPERIMENTAL
Intervention: Raltegravir (RAL)
Number of subjects: 0
Study 34523108 — intervention group
Group type: EXPERIMENTAL
Intervention: Prothrombin complex concentrates (PCC); median dose 1,000 units
Number of subjects: 415
Study 34523108 — intervention group
Group type: COMPARATOR
Intervention: Frozen plasma (FP); median dose 4 units
Number of subjects: 415
Study 36137670 — intervention group
Group type: EXPERIMENTAL
Intervention: LBBP‐CRT
Number of subjects: 40
Study 33303389 — intervention group
Group type: EXPERIMENTAL
Intervention: Nightly sildenafil 50 mg and sildenafil 100 mg on demand for sexual relations (up to 6 pills/month)
Number of subjects: 76
Study 33303389 — intervention group
Group type: EXPERIMENTAL
Intervention: Nightly sildenafil 50 mg (5 nights/week) plus intracavernosal injections twice/week
Number of subjects: 76
Study 33303389 — intervention group
Group type: COMPARATOR
Intervention: Nightly placebo with sildenafil 100 mg on demand for sexual relations (up to 6 pills/month)
Number of subjects: 76
Study 34626526 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedaquiline (BDQ)
Number of subjects: 429
Study 36655300 — intervention group
Group type: EXPERIMENTAL
Intervention: semaglutide 2.4 mg
Number of subjects: 174
Study 36655300 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 174
Study 33563758 — intervention group
Group type: EXPERIMENTAL
Intervention: Bot accounts identifying as Democratic or Republican, varying in strength of identification.
Number of subjects: 842
Study 32591103 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib maintenance therapy
Number of subjects: 0
Study 32591103 — intervention group
Group type: COMPARATOR
Intervention: Active surveillance (no maintenance therapy)
Number of subjects: 0
Study 32591103 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib maintenance therapy with 10% discount
Number of subjects: 0
Study 32591103 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib maintenance therapy with 20% discount
Number of subjects: 0
Study 35395952 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop automated oxygen control (CLAC)
Number of subjects: 70
Study 35395952 — intervention group
Group type: COMPARATOR
Intervention: Manual oxygen control
Number of subjects: 70
Study 34287530 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) therapy
Number of subjects: 18
Study 32717350 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive preventive intervention (API) designed to educate and motivate heavy-drinking college students; specific details on dosage and duration not available.
Number of subjects: 0
Study 32717350 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive preventive intervention (API); specific details on dosage and duration not available.
Number of subjects: 0
Study 36096312 — intervention group
Group type: EXPERIMENTAL
Intervention: Molecular point-of-care testing (mPOCT)
Number of subjects: 200
Study 36096312 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine clinical care)
Number of subjects: 200
Study 34129708 — intervention group
Group type: EXPERIMENTAL
Intervention: ARP using demineralized bovine bone mineral containing 10% collagen (DBBM-C) covered by a collagen matrix (CM) (n=25)
Number of subjects: 75
Study 34129708 — intervention group
Group type: EXPERIMENTAL
Intervention: ARP using demineralized bovine bone mineral containing 10% collagen (DBBM-C) covered with a palatal graft (PG) (n=25)
Number of subjects: 75
Study 34129708 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous healing (control) (n=25)
Number of subjects: 75
Study 33934677 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention based on the Theory of Planned Behavior (TPB)
Number of subjects: 30
Study 33934677 — intervention group
Group type: COMPARATOR
Intervention: Control group (nonintervention condition)
Number of subjects: 30
Study 33934677 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention
Number of subjects: 30
Study 32133391 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized, telephone‐based lifestyle intervention (diet, physical activity, behavior) with 19 calls over 2 years
Number of subjects: 338
Study 32133391 — intervention group
Group type: COMPARATOR
Intervention: Mail‐based educational material alone (control)
Number of subjects: 338
Study 35411792 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-Coated Balloon (DCB)
Number of subjects: 758
Study 35411792 — intervention group
Group type: COMPARATOR
Intervention: Drug-Eluting Stents (DES)
Number of subjects: 758
Study 36149735 — intervention group
Group type: EXPERIMENTAL
Intervention: eHealth lifestyle coaching program
Number of subjects: 340
Study 36149735 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 340
Study 32172425 — intervention group
Group type: EXPERIMENTAL
Intervention: Ganglion plexus ablation
Number of subjects: 240
Study 32172425 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 240
Study 32792107 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy plus small changes lifestyle intervention
Number of subjects: 139
Study 32792107 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 139
Study 35086535 — intervention group
Group type: EXPERIMENTAL
Intervention: In‐Service Teacher Training (INSETT) combined with Teaching Recovery Techniques (TRT)
Number of subjects: 0
Study 35086535 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer Integration and Enhancement Resources (PIER)
Number of subjects: 0
Study 35086535 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control condition
Number of subjects: 0
Study 32107930 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin Degludec/Liraglutide (IDegLira)
Number of subjects: 0
Study 32107930 — intervention group
Group type: COMPARATOR
Intervention: Basal-Bolus (BB) therapy (once-daily insulin glargine 100 U/mL and insulin aspart ≤4 times/day)
Number of subjects: 0
Study 616172268 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoballoon ablation (CB-G2)
Number of subjects: 34
Study 616172268 — intervention group
Group type: COMPARATOR
Intervention: Radiofrequency current (RFC) ablation
Number of subjects: 34
Study 36227782 — intervention group
Group type: EXPERIMENTAL
Intervention: Linaclotide 290 μg
Number of subjects: 2350
Study 36227782 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2350
Study 33306104 — intervention group
Group type: EXPERIMENTAL
Intervention: Aortic valve calcification
Number of subjects: 1769
Study 33306104 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitral valve calcification
Number of subjects: 1769
Study 32623059 — intervention group
Group type: EXPERIMENTAL
Intervention: Immersive tutorial in virtual reality (VR) as a teaching supplement
Number of subjects: 176
Study 32623059 — intervention group
Group type: COMPARATOR
Intervention: Control group (no immersive tutorial)
Number of subjects: 176
Study 32623059 — intervention group
Group type: EXPERIMENTAL
Intervention: Immersive tutorial in virtual reality (VR)
Number of subjects: 176
Study 36085103 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangaroo care
Number of subjects: 148
Study 36085103 — intervention group
Group type: EXPERIMENTAL
Intervention: Fetal position
Number of subjects: 148
Study 36085103 — intervention group
Group type: EXPERIMENTAL
Intervention: Swaddling
Number of subjects: 148
Study 36085103 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional peripheral vascular access without extra intervention)
Number of subjects: 148
Study 33878115 — intervention group
Group type: EXPERIMENTAL
Intervention: Chikungunya virus (CHIKV) seroprevalence
Number of subjects: 1981
Study 33878115 — intervention group
Group type: COMPARATOR
Intervention: Living conditions
Number of subjects: 1981
Study 33878115 — intervention group
Group type: EXPERIMENTAL
Intervention: Population density
Number of subjects: 1981
Study 33217593 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen combined with toremifene treatment
Number of subjects: 100
Study 33217593 — intervention group
Group type: COMPARATOR
Intervention: Toremifene
Number of subjects: 100
Study 37536514 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 kHz spinal cord stimulation plus conventional medical management (10 kHz SCS+CMM)
Number of subjects: 216
Study 37536514 — intervention group
Group type: COMPARATOR
Intervention: Conventional medical management (CMM) alone
Number of subjects: 216
Study 33542348 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulative incidence of diabetes
Number of subjects: 517
Study 33542348 — intervention group
Group type: EXPERIMENTAL
Intervention: Raw incidence rate
Number of subjects: 517
Study 33542348 — intervention group
Group type: EXPERIMENTAL
Intervention: Undiagnosed cases among incident cases
Number of subjects: 517
Study 33542348 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factors associated with diabetes
Number of subjects: 517
Study 33542348 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictive value of risk factors
Number of subjects: 517
Study 32664643 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching Games for Understanding (TGfU)
Number of subjects: 30
Study 32664643 — intervention group
Group type: COMPARATOR
Intervention: Direct Instruction (DI)
Number of subjects: 30
Study 35834373 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening strategy with machine learning risk prediction algorithm and diagnostic testing
Number of subjects: 334993
Study 35834373 — intervention group
Group type: COMPARATOR
Intervention: Routine care only
Number of subjects: 334993
Study 33272311 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard physical therapy plus battlefield acupuncture
Number of subjects: 0
Study 33272311 — intervention group
Group type: COMPARATOR
Intervention: Standard physical therapy
Number of subjects: 0
Study 33964569 — intervention group
Group type: EXPERIMENTAL
Intervention: n-back training (60 min/day; 4 days) in trained MS (MSt)
Number of subjects: 29
Study 33964569 — intervention group
Group type: EXPERIMENTAL
Intervention: n-back training (60 min/day; 4 days) in trained HC (HCt)
Number of subjects: 29
Study 33964569 — intervention group
Group type: EXPERIMENTAL
Intervention: n-back training (60 min/day; 4 days) in trained MS (MSt) and trained HC (HCt)
Number of subjects: 29
Study 33964569 — intervention group
Group type: COMPARATOR
Intervention: untrained MS (MSu)
Number of subjects: 29
Study 33964569 — intervention group
Group type: COMPARATOR
Intervention: untrained HC (HCu)
Number of subjects: 29
Study 32608120 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to recorded mother's voice via headphones
Number of subjects: 127
Study 32608120 — intervention group
Group type: COMPARATOR
Intervention: Wearing headphones without auditory stimuli (Control)
Number of subjects: 127
Study 35754036 — intervention group
Group type: EXPERIMENTAL
Intervention: Lowest SES group
Number of subjects: 306
Study 35754036 — intervention group
Group type: EXPERIMENTAL
Intervention: Screen time (hours)
Number of subjects: 306
Study 35754036 — intervention group
Group type: EXPERIMENTAL
Intervention: Childcare attendance
Number of subjects: 306
Study 35754036 — intervention group
Group type: COMPARATOR
Intervention: Childcare duration (years)
Number of subjects: 306
Study 32691141 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Abbreviated Burn Severity Index (mABSI)
Number of subjects: 2296
Study 34942595 — intervention group
Group type: EXPERIMENTAL
Intervention: High calcium pre-exercise meals (1,000 mg)
Number of subjects: 16
Study 34942595 — intervention group
Group type: COMPARATOR
Intervention: Low calcium pre-exercise meals (<50 mg)
Number of subjects: 16
Study 32377858 — intervention group
Group type: EXPERIMENTAL
Intervention: VITOM® system with VERSACRANE™ holding system
Number of subjects: 22
Study 32377858 — intervention group
Group type: COMPARATOR
Intervention: VITOM® system with ARTip™ cruise holding system
Number of subjects: 22
Study 33839130 — intervention group
Group type: COMPARATOR
Intervention: Moderate-risk patients
Number of subjects: 4262
Study 33839130 — intervention group
Group type: COMPARATOR
Intervention: High-risk patients
Number of subjects: 4262
Study 34706268 — intervention group
Group type: EXPERIMENTAL
Intervention: Behaviour change intervention provided by dental professionals
Number of subjects: 538
Study 34706268 — intervention group
Group type: EXPERIMENTAL
Intervention: Behaviour change intervention with power-brush
Number of subjects: 538
Study 34706268 — intervention group
Group type: COMPARATOR
Intervention: Standard oral hygiene advice (control)
Number of subjects: 538
Study 32307033 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-hospital emergency anaesthesia (PHEA) provided by UK Helicopter Emergency Medical Services (HEMS)
Number of subjects: 20
Study 34534233 — intervention group
Group type: EXPERIMENTAL
Intervention: Aceclofenac 100mg
Number of subjects: 384
Study 34534233 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoricoxib 90mg
Number of subjects: 384
Study 34534233 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucocorticoids
Number of subjects: 384
Study 34534233 — intervention group
Group type: EXPERIMENTAL
Intervention: Xanthine oxidase inhibitors
Number of subjects: 384
Study 33065552 — intervention group
Group type: EXPERIMENTAL
Intervention: ticagrelor/aspirin
Number of subjects: 339
Study 33065552 — intervention group
Group type: COMPARATOR
Intervention: clopidogrel/aspirin
Number of subjects: 339
Study 33065552 — intervention group
Group type: EXPERIMENTAL
Intervention: ticagrelor/aspirin (carriers)
Number of subjects: 339
Study 33065552 — intervention group
Group type: COMPARATOR
Intervention: clopidogrel/aspirin (carriers)
Number of subjects: 339
Study 33065552 — intervention group
Group type: EXPERIMENTAL
Intervention: ticagrelor/aspirin (non-carriers)
Number of subjects: 339
Study 33065552 — intervention group
Group type: COMPARATOR
Intervention: clopidogrel/aspirin (non-carriers)
Number of subjects: 339
Study 36165907 — intervention group
Group type: EXPERIMENTAL
Intervention: Cogmed working memory training (WMT), adaptive training, n = 28 PWH; nonadaptive training, n = 25 PWH; 25 sessions over 5–8 weeks.
Number of subjects: 106
Study 36165907 — intervention group
Group type: COMPARATOR
Intervention: Nonadaptive training, n = 23 SN.
Number of subjects: 106
Study 36165907 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive WMT
Number of subjects: 106
Study 34051134 — intervention group
Group type: EXPERIMENTAL
Intervention: Low FODMAPs diet
Number of subjects: 31
Study 34051134 — intervention group
Group type: COMPARATOR
Intervention: Usual dietary advice
Number of subjects: 31
Study 34051134 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 31
Study 32022618 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbinafine hydrochloride spray (THS) in combination with 3% boric acid alcohol (3% BAA) ear drops
Number of subjects: 320
Study 32022618 — intervention group
Group type: COMPARATOR
Intervention: 3% boric acid alcohol (3% BAA) ear drops
Number of subjects: 320
Study 616826658 — intervention group
Group type: EXPERIMENTAL
Intervention: Structural word puzzles
Number of subjects: 53
Study 616826658 — intervention group
Group type: EXPERIMENTAL
Intervention: Semantic/thematic word puzzles
Number of subjects: 53
Study 616826658 — intervention group
Group type: COMPARATOR
Intervention: Daily diary control group
Number of subjects: 53
Study 35406083 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-meal (low inflammatory potential)
Number of subjects: 11
Study 35406083 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutr-meal (moderate inflammatory potential)
Number of subjects: 11
Study 35406083 — intervention group
Group type: EXPERIMENTAL
Intervention: Pro-meal (high inflammatory potential)
Number of subjects: 11
Study 33709238 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese medicine (CM) involving triple rehabilitation therapy (electro‐acupuncture, Chinese medicinal herb fumigating‐washing, and traditional exercises)
Number of subjects: 696
Study 33709238 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation therapy (physical factor therapy, joint movement training, and muscle strength training)
Number of subjects: 696
Study 32758474 — intervention group
Group type: EXPERIMENTAL
Intervention: Liver transplantation after tumor downstaging
Number of subjects: 0
Study 32758474 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0